Exosomes Manufacturing Services

Delivering scalable, GMP-grade solutions for advanced exosome-based therapies.

Talk to an expert

Addressing Exosome Manufacturing Needs

Exosomes are nanoscale extracellular vesicles essential for cell-to-cell communication and therapeutic delivery. As regenerative medicine and cell therapy advance, exosome manufacturing has become a cornerstone for developing next-generation treatments.
However, the journey from concept to clinic is complex. Manufacturing exosomes for clinical and commercial use requires:

  • Efficient high-quality exosome production: Ensuring consistency, scalability, and purity for research, clinical, and commercial supply.
  • Maintaining exosome integrity and potency: Robust processes for isolation, purification, and storage are critical to preserve therapeutic efficacy.
  • Navigating regulatory and quality requirements: Meeting global standards for GMP, documentation, and traceability.

Cellipont Bioservices is dedicated to overcoming these challenges. Our advanced exosome manufacturing services support innovators at every stage, from early development through commercialization. We combine technical expertise, state-of-the-art facilities, and a collaborative approach to accelerate your program and maximize patient impact.

Our Capabilities

Cellipont Bioservices supports a diverse range of exosome manufacturing programs, including:

  • Process Development: Custom protocols for exosome isolation, purification, and characterization.
  • Scalable GMP Manufacturing: Flex Suites designed for seamless scale-up from preclinical to commercial volumes.
  • Quality Control: Advanced analytics for exosome purity, potency, and safety.
  • Technology Integration: Support for various cell sources, including allogeneic and autologous platforms.
  • Regulatory Support: Documentation and guidance for IND and BLA submissions.

Our manufacturing capabilities are built on flexibility and scalability, ensuring seamless transition from clinical development to commercial production.

Key Capabilities

Our team’s expertise in exosome manufacturing ensures your program benefits from best-in-class science, technology, and operational excellence.

GMP & Regulatory Compliance

Quality and compliance are at the heart of Cellipont’s manufacturing philosophy. We adhere to the highest global standards, including:

  • GMP (Good Manufacturing Practice): Rigorous protocols for facility management, documentation, and process control.
  • FDA & EMA Compliance: Systems designed to meet the requirements of major regulatory agencies, supporting global product registration and commercialization.

Our dedicated quality assurance team ensures every batch meets stringent specifications, giving clients confidence in product safety, efficacy, and regulatory readiness.

Why Choose Cellipont Bioservices

Choosing the right manufacturing partner is critical for the success of your exosome therapy program. Here’s why Cellipont stands out:

Proven Track Record

Proven Track Record

Decades of experience supporting clinical and commercial advanced therapy programs.

Collaborative Approach

Collaborative Approach

We work as an extension of your team, providing transparent communication and proactive problem-solving.

Technical Excellence

Technical Excellence

Our scientists and engineers are leaders in exosome manufacturing, process development, and regulatory strategy.

Flexible Solutions

Flexible Solutions

Customizable services to meet the unique needs of each client and therapy.

End-to-End Support

End-to-End Support

From cell sourcing to final product release, we manage every aspect of the manufacturing process.

What Our Customers Are Saying

"Cellipont’s world-class facility and deep expertise in cGMP manufacturing for cell and gene therapies make them an ideal manufacturing partner and align perfectly with our mission to deliver transformative therapies for cardiovascular diseases and beyond."

— Vinny Jindal, President and CEO of Secretome Therapeutics

Ready to take the next step in exosomes manufacturing?

Connect with Cellipont Bioservices today and discover how our expertise can accelerate your program and deliver life-changing therapies to patients worldwide.

Let’s work together

FAQs

Exosomes and EVs are nano-sized particles naturally released by cells that play a key role in cell-to-cell communication. They carry proteins, lipids, and genetic material, making them powerful tools for diagnostics, drug delivery, and regenerative medicine. Their ability to reflect the physiological state of their parent cells has made them a promising platform in precision medicine.

Cellipont Bioservices offers advanced biomanufacturing solutions tailored to the unique challenges of exosome and EV production. From upstream cell culture optimization to downstream purification and analytics, our team ensures scalable, GMP-compliant processes that accelerate your path to clinical and commercial success.

Scaling exosome production requires precise control over cell culture conditions, isolation techniques, and product characterization. Cellipont leverages deep expertise in cell therapy manufacturing and cutting-edge technologies to overcome these hurdles, delivering consistent, high-quality EVs that meet regulatory standards.

Absolutely. Our regulatory and scientific teams collaborate closely with clients to design robust development strategies, including IND-enabling studies, documentation, and regulatory submissions. We understand the evolving landscape of EV therapeutics and help you navigate it with confidence.